Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 3, 2010, Pages

  Costa, María A ^a   Elesgaray, Rosana ^a   Caniffi, Carolina ^a   Fellet, Andrea ^a   Mac Laughlin, Myriam ^a   Arranz, Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Aortic artery; Cardiovascular nitric oxide synthase; Heart; Hypertension; Natriuretic peptide receptors

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALMODULIN INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART; HYPERTENSION; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WISTAR RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; HYPERTENSION; MALE; MYOCARDIUM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SIGNAL TRANSDUCTION;

EID: 77749279565     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00488.2009     Document Type: Article

References (34)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
2. Anand-Srivastava MB. Natriuretic peptide receptor-C signaling and regulation. Peptides 26: 1044-1059, 2005.
3. Cheng PY, Chen JJ, Yen MH. The expression of heme oxigenase-1 and inducible nitric oxide synthase in aorta during the development of hypertension in spontaneously hypertensive rats. Am J Hypertens 17: 1127-1134, 2004.
4. Chou TC, Yen MH, Li CY, Ding YA. Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31: 643-648, 1998.
5. Costa MA, Gonzalez Bosc LV, Majowicz MP, Vidal NA, Balaszczuk AM, Arranz CT. Atrial natriuretic peptide modifies arterial blood pressure through nitric oxide pathway in rats. Hypertension 35: 1119-1123, 2000.
6. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C. Atrial natriuretic peptide influence on nitric oxide system in kidney and heart. Regul Pept 118: 151-157, 2004.
7. Costa MA, Loria A, Elesgaray R, Balaszczuk AM, Arranz C. Role of nitric oxide pathway in hypotensive and renal effects of furosemide during extracellular volume expansion. J Hypertens 22: 1-9, 2004.
8. Costa MA, Elesgaray R, Balaszczuk AM, Arranz C. Role of NPR-C natriuretic receptor in nitric oxide system activation induced by atrial natriuretic peptide. Regul Pept 135: 63-68, 2006.
9. Costa MA, Elesgaray R, Loria A, Balaszczuk AM, Arranz C. Vascular and renal effects of dopamine during extracellular volume expansion: role of nitric oxide pathway. Life Sci 78: 1543-1549, 2006.
10. Costa MA, Elesgaray R, Caniffi C, Fellet A, Arranz C. Role of cardiovascular nitric oxide system in C-type natriuretic peptide effects. Biochem Biophys Res Commun 359: 180-186, 2007.
11. Crabos M, Coste P, Paccalin M, Tariosse L, Daret D, Besse P, Bonoron-Adele S. Reduce basal NO-mediated dilation and decreased NO-synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 29: 55-65, 1997.
12. Dubois G. Decreased L-arginine-nitric oxide pathway in cultured myoblasts from spontaneously hypertensive versus normotensive Wistar-Kyoto rats. FEBS Lett 392: 242-244, 1996.
13. Elesgaray R, Caniffi C, Rodríguez Ierase D, Visintini Jaime MF, Fellet A, Arranz C, Costa MA. Signaling cascade that mediates endothelial nitric oxide synthase activation induced by atrial natriuretic peptide. Regul Pept 151: 130-134, 2008.
14. Förstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857, 1991.
15. Hong HJ, Hsiao G, Cheng TH, Yen MH. Supplementation with tetrahydrobiopterin suppresses the development of hypertension in spontaneously hypertensive rats. Hypertension 238: 1044-1048, 2001.
16. John SW, Veress AT, Honrath U, Chong CK, Peng L, Smithies O, Sonnenberg H. Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am J Physiol Regul Integr Comp Physiol 271: R109-R114, 1996.
17. Kagota S, Tada Y, Kubota Y, Nejime N, Yamaguchi Y, Nakamura K, Kunitomo M, Shinozuka K. Peroxynitrite is involved in the dysfunction of vasorelaxation in SHR/NDmcr-cp rats, spontaneously hypertensive rats. J Cardiovasc Pharmacol 50: 677-685, 2007.
18. Lee J, Kang DG, Kook H, Kim IK, Oh BS. Differentially-altered vascular guanylate cyclase isoforms in experimental hypertensive rats. J Korean Med Sci 14: 386-392, 1999.
19. Marcil J, Thibault C, Anand-Srivastava MB. Enhanced expression of Gi-protein precedes the development of blood pressure in spontaneously hypertensive rats. J Mol Cell Cardiol 29: 1009-1022, 1997.
20. Martin ER, Lewicki JA, Scarborough RM, Ballerman BJ. Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae. Am J Physiol Renal Fluid Electrolyte Physiol 257: F649-F657, 1989.
21. Melo LG, Steinhelper ME, Pang SC, Tse Y, Ackermann U. ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models. Physiol Genomics 3: 45-58, 2000.
22. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43: 109-142, 1991.
23. Nava E, Noll G, Luscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91: 2310-2313, 1995.
24. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 26: 901-932, 2005.
25. Pandey KN. Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation. J Am Soc Hypertens 2: 210-226, 2008.
26. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 57: 456-467, 2003.
27. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72, 2006.
28. Tremblay J, Huot C, Willenbrock RC, Bayard F, Gossard F, Fujio N, Koch C, Kuchel O, Debinski W, Hamet P. Increased cyclic guanosine monophosphate production and overexpression of atrial natriuretic peptide A-receptor mRNA in spontaneously hypertensive rats. J Clin Invest 92: 2499-2508, 1993.
29. Vapaatalo H, Mervaala E, Nurminen ML. Role of endothelium and nitric oxide in experimental hypertension. Physiol Res 49: 1-10, 2000.
30. Vaziri ND, Ni Z, Oveisi F. Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats. Hypertension 31: 1248-1254, 1998.
31. + when the Griess reaction is used to assay for nitrite. Anal Biochem 224: 502-508, 1995.
32. William M, Hamilton EJ, Garcia A, Bundgaard H, Chia KK, Figtree GA, Rasmussen HH. Natriuretic peptides stimulate the cardiac sodium pump via NPR-C-coupled NOS activation. Am J Physiol Cell Physiol 294: C1067-C1073, 2008.
33. Woodard GE, Zhao J, Rosado JA, Brown J. A-type natriuretic peptide receptor in the spontaneously hypertensive rat kidney. Peptides 23: 1637-1647, 2002.
34. Yamamoto M, Suzuki A, Hase TJ. Short-term effects of glucosyl hesperidin and hesperetin on blood pressure and vascular endothelial function in spontaneously hypertensive rats. Nutr Sci Vitaminol 54: 95-98, 200